Clearday, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223024846 Filed on July 18, 2023

Income Statement

Concept	2023 Q3	2023 Q1	2022 Q4

Balance Sheet

Concept	2023 Q3	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$99.81K	$81.43K	$195.6K
YoY Change		-35.29%	-79.73%
Cash & Equivalents	$99.81K	$81.43K	$195.6K
Short-Term Investments
Other Short-Term Assets	$377.7K	$124.1K
YoY Change		-96.33%
Inventory
Prepaid Expenses	$377.7K	$113.7K	$213.3K
Receivables		$58.45K	$47.71K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$477.5K	$264.0K	$466.6K
YoY Change	51.61%	-92.58%	-88.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.086M	$6.228M	$76.85K
YoY Change	-28.18%	-84.49%	-98.96%
Goodwill
YoY Change
Intangibles	$3.362M		$3.680M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$278.9K	$264.3K	$288.2K
YoY Change	-3.21%	-89.08%	0.0%
Total Long-Term Assets	$9.728M	$9.988M	$33.28M
YoY Change	-70.91%	-76.54%	-21.91%
TOTAL ASSETS
Total Short-Term Assets	$477.5K	$264.0K	$466.6K
Total Long-Term Assets	$9.728M	$9.988M	$33.28M
Total Assets	$10.21M	$10.25M	$33.75M
YoY Change	-69.77%	-77.78%	-27.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.449M	$3.599M	$6.324M
YoY Change	-44.85%	-16.21%	86.4%
Accrued Expenses	$6.137M	$6.438M	$8.416M
YoY Change	-20.07%	-42.41%	-8.55%
Deferred Revenue
YoY Change
Short-Term Debt	$2.025M	$708.4K	$672.6K
YoY Change	-36.02%	-82.66%	137.65%
Long-Term Debt Due	$19.88M	$16.75M	$16.35M
YoY Change	108.9%	282.4%	128.0%
Total Short-Term Liabilities	$39.63M	$32.35M	$39.32M
YoY Change	24.2%	19.9%	66.98%
LONG-TERM LIABILITIES
Long-Term Debt	$4.544M	$4.625M	$1.393M
YoY Change	316.47%	-16.82%	-75.0%
Other Long-Term Liabilities	$0.00	$0.00	$24.42M
YoY Change	-100.0%	-100.0%	-34.64%
Total Long-Term Liabilities	$4.544M	$4.625M	$1.393M
YoY Change	316.47%	-89.14%	-75.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$39.63M	$32.35M	$39.32M
Total Long-Term Liabilities	$4.544M	$4.625M	$1.393M
Total Liabilities	$44.18M	$48.01M	$65.13M
YoY Change	-24.73%	-40.64%	-2.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$86.22M	-$79.01M	-$79.67M
YoY Change	28.24%		22.18%
Common Stock	$26.16K	$25.19K	$20.81K
YoY Change	40.53%		39.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$63.65M	-$37.76M	-$63.55M
YoY Change
Total Liabilities & Shareholders Equity	$10.21M	$10.25M	$33.75M
YoY Change	-69.77%	-77.78%	-27.49%

Cashflow Statement

Concept	2023 Q3	2023 Q1	2022 Q4

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000895665
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent		usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q1	CLRD	Ppp Loan Forgiveness PppLoanForgiveness		usd
CY2022Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss		usd
CY2022Q1	CLRD	Fair Value Of Derivative FairValueOfDerivative		usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2022Q1	CLRD	Shares Issued For Loan Commitment SharesIssuedForLoanCommitment		usd
CY2022Q1	CLRD	Financing Costs From Derivative Liabilities FinancingCostsFromDerivativeLiabilities		usd
CY2022Q1	CLRD	Gain Loss On Termination Of Leases GainLossOnTerminationOfLeases		usd
CY2022Q1	CLRD	Series I Preferred Stock Accumulated Dividend SeriesIPreferredStockAccumulatedDividend		usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
CY2023Q1	CLRD	Gain On Pay Check Protection Program Loan Forgiveness GainOnPayCheckProtectionProgramLoanForgiveness		usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets		usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities		usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2023Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
CY2023Q1	CLRD	Payments To Acquire Property And Equipment PaymentsToAcquirePropertyAndEquipment		usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
CY2023Q1	CLRD	Repayments Of Lease Obligations RepaymentsOfLeaseObligations		usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	CLRD	Early Lease Termination Fee EarlyLeaseTerminationFee		usd
CY2022Q1	CLRD	Settlements On Derivative Liability SettlementsOnDerivativeLiability		usd
CY2022Q1	CLRD	Converted Preferred Shares Series F To Common Shares ConvertedPreferredSharesSeriesFToCommonShares		usd
CY2022Q1	CLRD	Paid In Kind Dividends For Series F Preferred Shares PaidInKindDividendsForSeriesFPreferredShares		usd
CY2022Q1	CLRD	Debt Discount On Derivative Liability DebtDiscountOnDerivativeLiability		usd
CY2023Q1	CLRD	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour		usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense		usd
CY2023Q1	CLRD	Disposal Group Including Discontinued Operation Gain On Disposal Of Assets DisposalGroupIncludingDiscontinuedOperationGainOnDisposalOfAssets		usd
CY2023Q1	us-gaap	Income Loss Of Discontinued Operation Equity Method Investment Retained After Disposal Before Income Tax IncomeLossOfDiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalBeforeIncomeTax		usd
CY2023Q1	CLRD	Disposal Group Including Discontinued Operation Impairment Expense Recovery DisposalGroupIncludingDiscontinuedOperationImpairmentExpenseRecovery		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	0-21074
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CLEARDAY, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0158076
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	8800 Village Drive
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 106
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Antonio
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	78217
CY2023Q1	dei	City Area Code CityAreaCode	(210)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	451-0839
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2907605	usd
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2023Q1	dei	Trading Symbol TradingSymbol	CLRD
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25997628	shares
CY2023Q1	us-gaap	Cash Cash	81429	usd
CY2022Q4	us-gaap	Cash Cash	195638	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	10000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	58447	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47705	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	113666	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	213289	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	466	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	264008	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	466632	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22792752	usd
CY2023Q1	CLRD	Land And Buildings LandAndBuildings	5817999	usd
CY2022Q4	CLRD	Land And Buildings LandAndBuildings	5872045	usd
CY2023Q1	CLRD	Leasehold Improvements LeaseholdImprovements	269984	usd
CY2022Q4	CLRD	Leasehold Improvements LeaseholdImprovements	435899	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1795	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76848	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	138187	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	138187	usd
CY2023Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	3496000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	3680000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	264251	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	288155	usd
CY2023Q1	us-gaap	Assets Assets	10252224	usd
CY2022Q4	us-gaap	Assets Assets	33750518	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3599141	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6324002	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5966110	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8415609	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3748918	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2320547	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	471684	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	294370	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	13466	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	901235	usd
CY2023Q1	CLRD	Long Terms Debt Current LongTermsDebtCurrent	16746935	usd
CY2022Q4	CLRD	Long Terms Debt Current LongTermsDebtCurrent	16347290	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	32350632	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39323361	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24415791	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4624723	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1392940	usd
CY2023Q1	us-gaap	Liabilities Liabilities	36975355	usd
CY2022Q4	us-gaap	Liabilities Liabilities	65132092	usd
CY2023Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0675	pure
CY2022	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0675	pure
CY2023Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	4791401	shares
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	4791401	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	4797052	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	4797052	shares
CY2023Q1	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	102380677	usd
CY2022Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	101162577	usd
CY2023Q1	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	22033843	usd
CY2022Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	20448079	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	329	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	329	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25194402	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25194402	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20805448	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20805448	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	25194	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	20805	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19193946	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16098182	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-79011020	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-79671065	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-59791551	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-63551749	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	11034577	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	11722096	usd
CY2023Q1	CLRD	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Of Subsidiaries StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestOfSubsidiaries	-48756974	usd
CY2022Q4	CLRD	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Of Subsidiaries StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestOfSubsidiaries	-51829653	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10252224	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33750518	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3006504	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3210218	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3815150	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4634056	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	880485	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1393370	usd
CY2023Q1	us-gaap	Depreciation Depreciation	324044	usd
CY2022Q1	us-gaap	Depreciation Depreciation	187215	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5019679	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	6214641	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2013175	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3004423	usd
CY2023Q1	CLRD	Interest Expenses InterestExpenses	549033	usd
CY2022Q1	CLRD	Interest Expenses InterestExpenses	501598	usd
CY2022Q1	CLRD	Ppp Loan Forgiveness PppLoanForgiveness	-642816	usd
CY2023Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-2567460	usd
CY2023Q1	CLRD	Fair Value Of Derivative FairValueOfDerivative	-1565232	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-192407	usd
CY2023Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	4530644	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-653814	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10897	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	143889	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2122265	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	285107	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	109090	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2719316	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-85227	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	109090	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2804543	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	550955	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	144265	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1698784	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1619015	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2140649	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4567823	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.18
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24187743	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15010907	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-36792907	usd
CY2022Q1	CLRD	Stock Issued During Period Value Stock Dividend One StockIssuedDuringPeriodValueStockDividendOne	-1619015	usd
CY2022Q1	CLRD	Stock Issued During Period Value Series F Incentive Common Stock StockIssuedDuringPeriodValueSeriesFIncentiveCommonStock	6	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	113020	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	113020	shares
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	136564	usd
CY2022Q1	CLRD	Series I Adjustment SeriesIAdjustment	-669904	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	0	usd
CY2022Q1	CLRD	Stock Issued During Period Value Shares Issued For Loan StockIssuedDuringPeriodValueSharesIssuedForLoan	0	usd
CY2022Q1	CLRD	Adjustment To Additional Paid In Capital Dissolution Of Longhorn Hospitality AdjustmentToAdditionalPaidInCapitalDissolutionOfLonghornHospitality	0	usd
CY2022Q1	CLRD	Stock Issued During Period Value Redemption Of Series F Shares StockIssuedDuringPeriodValueRedemptionOfSeriesFShares	0	usd
CY2022Q1	CLRD	Stock Issued During Period Value Officer Compensation And Debt Conversion StockIssuedDuringPeriodValueOfficerCompensationAndDebtConversion	0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2948808	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-41894064	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-51829653	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-51829653	usd
CY2023Q1	CLRD	Stock Issued During Period Value Stock Dividend One StockIssuedDuringPeriodValueStockDividendOne	-1698784	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	113020	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-136564	usd
CY2023Q1	CLRD	Stock Issued During Period Value Derivative Payment Discount StockIssuedDuringPeriodValueDerivativePaymentDiscount	713435	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	0	usd
CY2023Q1	CLRD	Stock Issued During Period Value Shares Issued For Loan StockIssuedDuringPeriodValueSharesIssuedForLoan	70686	usd
CY2023Q1	CLRD	Stock Issued During Period Value For Extinguishment Of Debt StockIssuedDuringPeriodValueForExtinguishmentOfDebt	3901796	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	109090	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-48756975	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-48756975	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	109090	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2804543	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-85227	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	109090	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2719316	usd
CY2023Q1	us-gaap	Depreciation Depreciation	324044	usd
CY2022Q1	us-gaap	Depreciation Depreciation	187215	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	459750	usd
CY2023Q1	CLRD	Shares Issued For Loan Commitment SharesIssuedForLoanCommitment	70686	usd
CY2023Q1	CLRD	Financing Costs From Derivative Liabilities FinancingCostsFromDerivativeLiabilities	2567460	usd
CY2023Q1	CLRD	Gain Loss On Termination Of Leases GainLossOnTerminationOfLeases	4530644	usd
CY2023Q1	CLRD	Series I Preferred Stock Accumulated Dividend SeriesIPreferredStockAccumulatedDividend	136564	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-192407	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	179854	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	1565232	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	241504	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	501970	usd
CY2023Q1	CLRD	Amortization Of Discount On Derivatives AmortizationOfDiscountOnDerivatives	540760	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-653814	usd
CY2022Q1	CLRD	Gain On Pay Check Protection Program Loan Forgiveness GainOnPayCheckProtectionProgramLoanForgiveness	642816	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	190596	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6145	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-23438	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-99623	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	433839	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	523121	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	902548	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-181935	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	746362	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-887769	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	35769	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-44094	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	113000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-227777	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1046967	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2035055	usd
CY2022Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-45421	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1046967	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2080476	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37437	usd
CY2022Q1	CLRD	Payments To Acquire Property And Equipment PaymentsToAcquirePropertyAndEquipment	13348	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37437	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13348	usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	977263	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	1534560	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	649121	usd
CY2022Q1	CLRD	Repayments Of Lease Obligations RepaymentsOfLeaseObligations	12929498	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2130268	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	885439	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14082503	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations	-114209	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations	-895398	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations	195638	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations	56159	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	975075	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	91429	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	135836	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81429	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	125836	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	10000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	10000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	91429	usd
CY2023Q1	CLRD	Classification Of Redeemable Convertible Preferred Stock Description ClassificationOfRedeemableConvertiblePreferredStockDescription	Registrants having such securities outstanding are required to present separately, in balance sheets, amounts applicable to the following three general classes of securities: (i) preferred stocks subject to mandatory redemption requirements or whose redemption is outside the control of the issuer; (ii) preferred stocks which are not redeemable or are redeemable solely at the option of the issuer; and (iii) common stocks. In addition, the rules require disclosure of redemption terms, five-year maturity data, and changes in redeemable preferred stock.
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	135836	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	195638	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	965075	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	10000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	10000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	205638	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	975075	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	649121	usd
CY2023Q1	CLRD	Early Lease Termination Fee EarlyLeaseTerminationFee	22751358	usd
CY2023Q1	CLRD	Settlements On Derivative Liability SettlementsOnDerivativeLiability	713435	usd
CY2023Q1	CLRD	Converted Preferred Shares Series F To Common Shares ConvertedPreferredSharesSeriesFToCommonShares	294140	usd
CY2023Q1	CLRD	Paid In Kind Dividends For Series F Preferred Shares PaidInKindDividendsForSeriesFPreferredShares	1698784	usd
CY2023Q1	CLRD	Debt Discount On Derivative Liability DebtDiscountOnDerivativeLiability	1826735	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-79011020	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	109090	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1046967	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-14462738	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3978027	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zfVgPZNh6QW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zJpYCJTbOTvd">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial statement preparation requires that management make estimates and assumptions which affect the reporting of assets and liabilities and the related disclosure of contingent assets and liabilities in order to report these financial statements in conformity with GAAP. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2023Q1	CLRD	Schedule Of Revenue From Contract With Customers ScheduleOfRevenueFromContractWithCustomers	<p id="xdx_892_ecustom--ScheduleOfRevenueFromContractWithCustomers_zQnwlMBvGaOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below is a table that shows the breakdown by percentage of revenues related to contracts with residents versus resident fees for support or ancillary services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zCtPKpu9Kpoi" style="display: none">Schedule of Revenue from Contract with Customers</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">For the periods ended March 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">%</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">%</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Revenue from contracts with customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left">Resident rent - over time</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span id="xdx_900_eus-gaap--Revenues_c20230101__20230331__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zIoyqtUqd533">2,895,326</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zlVk2Hphq2n5">96</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span id="xdx_908_eus-gaap--Revenues_c20220101__20220331__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zAk2qClaqU4j">3,124,761</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zcROOvSYIGob">97</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Day care</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--Revenues_c20230101__20230331__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--TransferredDayCareMember_z91h4dC9Brif">89,041</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--TransferredDayCareMember_zZVROqKPHYU">3</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--Revenues_c20220101__20220331__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--TransferredDayCareMember_zqKk0BsfWoF">83,896</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--TransferredDayCareMember_zdHiG14oSx03">3</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Amenities and conveniences - point in time</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_c20230101__20230331__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_z7LS0NsqC7la">22,137</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_z3dLWMz71Ngh" title="Concentration risk, percentage">1</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--Revenues_c20220101__20220331__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zfKxGX7YoK9j">1,561</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_z4j2vca9hIJ" title="Concentration risk, percentage">0</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue from contracts with customers</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90A_eus-gaap--Revenues_c20230101__20230331_zaGLcIB1boRl">3,006,504</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zLhw8hGAMJld">100</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--Revenues_c20220101__20220331_zBbTuXGnyAs1">3,210,218</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHlQmJx4YAt8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> </table>
CY2023Q1	us-gaap	Revenues Revenues	3006504	usd
CY2022Q1	us-gaap	Revenues Revenues	3210218	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	3748918	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2320547	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0360	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0494	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.82	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	4.21	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0399	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0476	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.83	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	5.72	pure
CY2022Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2240000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2023Q1	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	greater than 50% likelihood
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	3496000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	552000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	736000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	736000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	736000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	736000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3496000	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	14239	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	36636	usd
CY2023Q1	CLRD	Disposal Group Including Discontinued Operation Operating Expense Net DisposalGroupIncludingDiscontinuedOperationOperatingExpenseNet	36636	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-22307	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	44151	usd
CY2023Q1	CLRD	Disposal Group Including Discontinued Operation Other Income Expense DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense	18768	usd
CY2023Q1	CLRD	Disposal Group Including Discontinued Operation Income Expense Net DisposalGroupIncludingDiscontinuedOperationIncomeExpenseNet	62920	usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-85227	usd
CY2023Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	549033	usd
CY2022Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	501598	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	6839277	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	9635591	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1494886	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	4461182	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	494900	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	22925835	usd
CY2022Q4	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	2801365	usd
CY2022Q3	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	3012011	usd
CY2022Q3	us-gaap	Cash Cash	2763936	usd
CY2022Q3	CLRD	Payment Of Amount PaymentOfAmount	248075	usd
CY2022Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	311000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1097000	usd
CY2023Q1	CLRD	Accrued Underpayment Excluding Taxes Penalties And Interest AccruedUnderpaymentExcludingTaxesPenaltiesAndInterest	978000	usd
CY2022Q4	CLRD	Accrued Underpayment Excluding Taxes Penalties And Interest AccruedUnderpaymentExcludingTaxesPenaltiesAndInterest	527000	usd
CY2023Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2925195	usd
CY2023Q1	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	1531640	usd
CY2023Q1	us-gaap	Participating Mortgage Loans Mortgage Obligations Amount ParticipatingMortgageLoansMortgageObligationsAmount	875000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-02-10
CY2023Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	467451	usd
CY2023Q1	CLRD	Percentage Of Fee Payable PercentageOfFeePayable	0.02	pure
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13521004	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9586495	shares
CY2023Q1	CLRD	Guarantee Fee Percentage GuaranteeFeePercentage	0.01	pure
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4218158	shares
CY2023Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Each holder of common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors
CY2023Q1	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	(1) the preferred stock designated as the Series I 10.25% cumulative convertible preferred stock, par value $0.01 per share of AIU Alt Care (the “Alt Care Preferred Stock”); and (2) the preferred limited partnership interests of Clearday OZ Fund (the “Clearday OZ LP Interests”)
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4218158	shares
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P10Y
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.00
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	682820	usd

Files In Submission

Name	View Source	Status
0001493152-23-024846-index-headers.html	Edgar Link	pending
0001493152-23-024846-index.html	Edgar Link	pending
0001493152-23-024846.txt	Edgar Link	pending
0001493152-23-024846-xbrl.zip	Edgar Link	pending
clrd-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
clrd-20230331_def.xml	Edgar Link	unprocessable
clrd-20230331_lab.xml	Edgar Link	unprocessable
clrd-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
clrd-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Clearday, Inc.

2023 Q3 Form 10-Q Financial Statement

#000149315223024846 Filed on July 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission